Lupin secures USFDA tentative nod for Brimonidine Tartrate Ophthalmic Solution Ruchika Sharma17 Aug 2024 11:33 AM ISTMumbai: Global pharma major Lupin Limited has announced that the Company has received tentative approval from the United States Food and Drug...
Gland Pharma bags tentative USFDA nod for Latanoprostene Bunod Ophthalmic Solution Ruchika Sharma24 July 2024 11:30 AM ISTHyderabad: Generic injectable-focused pharmaceutical company, Gland Pharma Limited, has received tentative approval from the United States...
Alembic Pharma bags USFDA nod for Bromfenac Ophthalmic Solution Ruchika Sharma9 July 2024 2:47 PM ISTVadodara: Alembic Pharmaceuticals Limited has announced that the Company has received final approval from the US Food & Drug Administration...
Lupin bags USFDA approval for Loteprednol Etabonate Ophthalmic Suspension Ruchika Sharma26 April 2024 11:40 AM ISTMumbai: Global pharma major Lupin Limited has announced that the Company has received approval from the United States Food and Drug...
Lupin unveils Bromfenac Ophthalmic Solution in US Ruchika Sharma10 Jan 2024 11:28 AM ISTIt is indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.
USFDA approves Lupin Bromfenac Ophthalmic Solution Ruchika Sharma24 Nov 2023 12:30 PM ISTBromfenac Ophthalmic Solution, 0.07% is indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have...
Bausch + Lomb acquires JnJ eye, contact lens drops brand Blink for USD 106.5 million Ruchika Sharma7 July 2023 3:10 PM ISTBausch + Lomb acquired Johnson & Johnson's eye and contact lens drops brand Blink for $106.5 million, marking its second deal in two weeks to...
Novartis to divest 'front of eye' ophthalmology assets to Bausch + Lomb for up to 2.5 billion Ruchika Sharma3 July 2023 3:30 PM ISTNovartis will continue to supply Xiidra to patients on behalf of Bausch + Lomb, via transitional agreements for a limited period post-close, to ensure...
FDA Approves Perfluorohexyloctane Ophthalmic Solution for Treatment of Dry Eye Disease Dr. Kamal Kant Kohli22 May 2023 11:30 AM ISTDry eye disease (DED) affects millions of Americans and is one of the most common ocular surface disorders.A leading cause of DED is excessive tear...
